相关实验视频

Updated: Jul 12, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

表皮生长因子在糖尿病足的治疗中优于安慰剂:一个元分析

Fazal Rahim¹, Xie Yan^2,3, Jawad Ali Shah⁴

¹Burn and Plastic Surgery department, General Hospital of Ningxia Medical University, Yinchuan, P.R. China, Yinchuan, 750004, China.

|October 23, 2023

概括

皮表皮生长因子 (EGF) 与安慰剂相比,显著提高了糖尿病足的愈合率. 这一元分析表明,EGF是这些具有挑战性的伤口的有效和安全的治疗选择.

科学领域:

伤口治愈研究研究伤口治愈研究
糖尿病学糖尿病学
再生医学是一种再生医学.

背景情况:

糖尿病足 (DFU) 是糖尿病的严重并发症,通常导致严重的发病率.
增长因素表明DFU治疗的潜力,但证据是相互矛盾的.
进行了一项元分析,以评估表皮生长因子 (EGF) 与安慰剂对DFU愈合的疗效.

研究的目的:

为了比较表皮生长因子 (EGF) 与安慰剂在治疗糖尿病足的疗效和安全性.
提供对EGF用于DFU治疗的随机对照试验的综合元分析.

主要方法:

在Cochrane图书馆,PubMed,谷歌学者,Elsevier和EMBASE (2009-2021) 的系统文献搜索.
在1型和2型糖尿病患者的随机对照试验 (RCT) 中,包括患有脚伤的患者.
评估研究质量,重点关注随机化,盲目化和结果数据中的偏见.

主要成果:

分析了8个RCT,包括620名患者 (337名EGF,283名安慰剂).
在4周 (RR:3.04) 和8周 (RR:2.59) 中,EGF的完全治愈率明显高于安慰剂.
在4周后,治愈频率为EGF的34%,与安慰剂的17%相比.

结论:

皮表皮生长因子 (EGF) 在糖尿病足中显著加快伤口愈合.
EGF是治疗糖尿病足的安全有效的治疗方案.
这些发现支持了EGF对DFU处理方案的建议.

关键词:

糖尿病足部糖尿病足部进行元分析分析.避孕药是一种安慰剂.皮肤表皮生长因子

更多相关视频

A Simplified Technique for Producing an Ischemic Wound Model

A Simplified Technique for Producing an Ischemic Wound Model

Published on: May 2, 2012

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...